Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aziz Rasooli

Podiatrist Rancho Palos Verdes, CA Doctor of Podiatric Medicine

NPI 1194295469 CMS profile 5691369

50 Rockinghorse Rd, Rancho Palos Verdes, CA 90275

Open in the dashboard

General payments

$54,786

405 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aziz Rasooli of Rancho Palos Verdes, CA is reported in the CMS Open Payments database as having received $54,786 across 405 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $487 8
2024 General $2,426 37
2023 General $19,777 84
2022 General $25,357 140
2021 General $5,195 108
2020 General $975 23
2019 General $569 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aziz Rasooli
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Aziz Rasooli were reported at $487. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Aziz Rasooli Podiatrist median Middle half National median
2019 $569 $196 $72–$601 $163
2020 $975 $118 $38–$335 $114
2021 $5,195 $169 $57–$573 $132
2022 $25,357 $220 $74–$782 $149
2023 $19,777 $208 $71–$635 $160
2024 $2,426 $237 $87–$681 $164
2025 $487 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. TissueTech, Inc. $19,669 58 payments
  2. Stryker Corporation $14,616 252 payments
  3. Flower Orthopedics Coporation $12,268 11 payments
  4. Medline Industries, Inc. $4,072 18 payments
  5. Saxum Surgical, Inc. $1,238 2 payments
  6. Smith+Nephew, Inc. $1,014 27 payments
  7. Orthofix Medical, Inc. $356 2 payments
  8. Zimmer Biomet Holdings, Inc. $354 8 payments
  9. Wright Medical Technology, Inc. $230 4 payments
  10. PolyNovo North America LLC $212 3 payments
  11. Other $756 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $21,354 13 payments
  2. Food and Beverage $20,654 367 payments
  3. Travel and Lodging $8,368 22 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $3,200 1 payment
  5. Education $1,200 1 payment
  6. Gift $10 1 payment
Products named General payments · program years 2019–2025
  1. NEOX $9,665 48 payments
  2. MEDLINE UNITE $8,769 34 payments
  3. CLARIX $5,188 43 payments
  4. ACTISHIELD $5,008 82 payments
  5. ACTISHIELD CF $2,795 55 payments
  6. Flex-Thread Ulna Orthopedic Implant $2,600 2 payments
  7. Flex-Thread Ulna Orthopedic Implant $2,600 2 payments
  8. Flex-Thread Ulna Orthopedic Implant $2,600 2 payments
  9. Flex-Thread Ulna Orthopedic Implant $2,600 2 payments
  10. Flex-Thread Ulna Orthopedic Implant $2,600 2 payments
  11. Other $20,311 211 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$105,312

Medicare's payments for the services billed

Medicare patients

238

Average age 74

Services billed

1,169

124 women, 114 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 73%
Arthritis 71%
Depression 63%
Chronic kidney disease 60%
Alzheimer's or dementia 55%
Heart failure 53%
Ischemic heart disease 50%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

405 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record